COMMUNIQUÉS West-GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/01/2026
SAN FRANCISCO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
TEL AVIV, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the 44 th Annual J.P. Morgan [...]
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/01/2026
CHARLESTOWN, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today [...]
Enovis Appoints Oliver Engert as Chief Administrative Officer
05/01/2026
Dallas, TX, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, has announced that Oliver Engert has been appointed Chief Administrative Officer, [...]
Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
SALT LAKE CITY, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Sam Raha, president and CEO, will present at [...]
KALA BIO Settles Approximately $10.6 million of Debt
05/01/2026
ARLINGTON, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), (“KALA” or the “Company”) today announced the successful completion of its loan settlement with Oxford Finance, LLC (“Oxford”), marking a [...]
The Joint Corp. Appoints Ron Stilwell SVP Operations and Patient Experience
05/01/2026
Brings more than 30 Years of Operational Enhancement Success for Leading Franchisors Across Multiple Industries SCOTTSDALE, Ariz., Jan. 05, 2026 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest [...]
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/01/2026
CAMBRIDGE, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one newly- [...]
Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
MOUNTAIN VIEW, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today announced that members [...]
AVITA Medical Announces Changes to its Board of Directors
05/01/2026
Veteran healthcare executive Joe Woody joins the Board Lou Panaccio retires after over a decade of service VALENCIA, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (ASX: AVH, NASDAQ: RCEL), a leading [...]
Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
SAN JOSE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, [...]
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
05/01/2026
SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]
Revolution Medicines to Present at 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
REDWOOD CITY, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
05/01/2026
ZUG, Switzerland, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The attached notification relates to the vesting and settlement of RSUs previously granted to a director of the Company. Attachment Notification of managers' [...]
Citrus Burn Examined (URGENT REPORT) The Science Behind the Orange Peel Trick for Metabolic Support
05/01/2026
New York City, Jan. 05, 2026 (GLOBE NEWSWIRE) -- January 5, 2026 Citrus Burn is a citrus-derived dietary supplement formulated to support metabolism, daily energy levels, and thermogenic activity through plant-based [...]
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
05/01/2026
SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) (“Crinetics”), a pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace
05/01/2026
VANCOUVER, British Columbia, Jan. 05, 2026 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 Labs, Inc. (OTC: FITY ) today issues the following clarification regarding its press release dated August 26, 2025, which referenced a [...]
SAFE - DEMISSION DE RODOLPHE CADIO ET NOMINATION DE NICOLAS PAPILLON AU CONSEIL D'ADMINISTRATION
05/01/2026
DEMISSION DE RODOLPHE CADIO ET NOMINATION DE NICOLAS PAPILLON AU CONSEIL D'ADMINISTRATION Fleurieux-sur-l’Arbresle – France – 5 janvier 2026 – 18h - Safe (FR001400ZU25 – ALSAF), annonce la démission de Rodolphe Cadio de [...]
Plum Tree Launches 2026 with Expanded Access to Mental Health Care for Children and Adolescents
05/01/2026
ST. CHARLES, Ill., Jan. 05, 2026 (GLOBE NEWSWIRE) -- As families enter the new year, Plum Tree Psychology, a child and adolescent behavioral health practice serving Kane County and surrounding communities, is expanding [...]

Pages